Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liquid Biopsy: Intercepting Mutational Trajectories of HER2 Breast Cancer Inpatients Under T-DM1 Treatment

NCT05735392 is registered in ClinicalTrials.gov with Consorzio Oncotech as lead sponsor.

NCT NCT05735392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05735392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liquid Biopsy: Intercepting Mutational Trajectories of HER2 Breast Cancer Inpatients Under T-DM1 Treatment
Lead sponsor
Consorzio Oncotech
Phase
Not applicable
Overall status
Completed
Start date
November 7, 2018
Completion date
January 12, 2022
Enrollment
48 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer